Although there were no suitable datasets collected from lung cancer trials, data from two recent clinical trials of nivolumab in advanced melanoma [49, 50] were used to compare patient response to treatment when patients were stratified by level of DRD1 mRNA expression. Here, DRD1 is linked to melanoma.